Table 4 Diabetic complications at 10 years of diabetes duration
From: Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation
T1DM | LADA | P | |
|---|---|---|---|
Microvascular complications, n/total (%) | 4/19 (21.1%) | 19/30 (63.3%) | 0.004* |
Peripheral neuropathy, n/total (%) | 0/19 (0.0%) | 3/30 (10.0%) | 0.273 |
Retinopathy, n/total (%) | 0/18 (0.0%) | 3/26 (11.5%) | 0.258 |
Nephropathy, n/total (%) | 4/17 (23.5%) | 16/30 (53.3%) | 0.047* |
GFR (mL/min), median (IQR) [n] | 98.0 (19.8) [16] | 93.0 (23.5) [28] | 0.102 |
GFR < 90 mL/min, n/total (%) | 4/16 (25.0%) | 13/28 (46.4%) | 0.160 |
GFR < 60 mL/min, n/total (%) | 2/16 (12.5%) | 8/28 (28.6%) | 0.283 |
Albumin/creatinine ratio (mg/g), median (IQR) [n] | 3.8 (12.4) [15] | 8.7 (16.6) [26] | 0.149 |
Albuminuria A3, n/total (%) | 0/15 (0.0%) | 3/26 (11.5%) | 0.287 |
Macrovascular complications, n/total (%) | 4/20 (20.0%) | 1/31 (3.2%) | 0.071 |
Ischemic Heart Disease, n/total (%) | 1/19 (5.3%) | 1/31 (3.2%) | 1.000 |
Cerebrovascular disease, n/total (%) | 3/19 (15.8%) | 0/30 (0.0%) | 0.053 |
Peripheral artery disease, n/total (%) | 1/20 (5.0%) | 0/31 (0.0%) | 0.392 |